These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1972136)

  • 1. Rationale for very high-dose chemotherapy with peripheral blood stem cell support in advanced ovarian cancer.
    Panici PB; Scambia G; Baiocchi G; Laurelli G; Greggi S; Battaglia F; Ragusa G; Salerno G; Gallo A; Cento R
    Haematologica; 1990; 75 Suppl 1():87-9. PubMed ID: 1972136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer.
    Donato ML; Gershenson DM; Wharton JT; Ippoliti CM; Aleman AS; Bodurka-Bevers D; Bevers MW; Burke TW; Levenback CF; Wolf JK; Freedman RS; Bast RC; Gajewski JL; Champlin RE
    Gynecol Oncol; 2001 Sep; 82(3):420-6. PubMed ID: 11520135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT).
    Bengala C; Guarneri V; Ledermann J; Rosti G; Wandt H; Lotz JP; Cure JH; Orlandini C; Ferrante P; Conte PF; Demirer T;
    Bone Marrow Transplant; 2005 Jul; 36(1):25-31. PubMed ID: 15908977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: analysis of 67 patients treated in a single institution.
    Bertucci F; Viens P; Gravis G; Blaise D; Faucher C; Oziel-Taoeb S; Bardou VJ; Jacquemier J; Delpero JR; Maraninchi D
    Anticancer Res; 1999; 19(2B):1455-61. PubMed ID: 10365123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study.
    Gonçalves A; Delva R; Fabbro M; Gladieff L; Lotz JP; Ferrero JM; Linassier C; Cottu PH; Viens P; Extra JM
    Bone Marrow Transplant; 2006 Apr; 37(7):651-9. PubMed ID: 16501596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors].
    Lotz JP; Pene F; Bouleuc C; André T; Gligorov J; Avenin D; Esteso A; Bellaiche A; Macovei C; Merad Z; Laadem A; Vanica R; Izrael V
    Contracept Fertil Sex; 1996 Apr; 24(4):307-18. PubMed ID: 8704806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-dose chemotherapy (HDCT) with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer patients with poor prognosis].
    Hayakawa S; Sato S; Yajima A
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1756-61. PubMed ID: 7574806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High-dose chemotherapy with stem cell support for solid tumors in adults].
    Rodenhuis S; de Vries EG
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):731-8. PubMed ID: 10347628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer: results of a Phase I study.
    Prince HM; Rischin D; Quinn M; Allen D; Planner R; Neesham D; Gates P; Davison J
    Gynecol Oncol; 2001 May; 81(2):216-24. PubMed ID: 11330952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
    Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
    Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature].
    Viens P; Bertucci F; Gravis G; Camerlo J; Cowen D; Delpero JR; Conte M; Jacquemier J; Faucher C; Blaise D; Bardou VJ; Chabannon C; Blanc AP; Jaubert D; Maraninchi D
    Bull Cancer; 1997 Sep; 84(9):869-76. PubMed ID: 9435808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose chemotherapy and stem cell support in the treatment of germ cell cancer.
    Margolin K
    J Urol; 2003 Apr; 169(4):1229-33. PubMed ID: 12629333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer.
    Donato ML; Gershenson D; Ippoliti C; Wharton JT; Bast RC; Aleman A; Anderlini P; Gajewski JG; Giralt S; Molldrem J; Ueno N; Lauppe J; Korbling M; Boyer J; Bodurka-Bevers D; Bevers M; Burke T; Freedman R; Levenback C; Wolf J; Champlin RE
    Bone Marrow Transplant; 2000 Jun; 25(11):1137-40. PubMed ID: 10849525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer.
    Wandt H; Birkmann J; Denzel T; Schäfer K; Schwab G; Pilz D; Egger H; Both A; Gallmeier WM
    Bone Marrow Transplant; 1999 Apr; 23(8):763-70. PubMed ID: 10231137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation.
    Donato ML; Aleman A; Champlin RE; Saliba RM; Wharton JT; Burke TW; Bodurka DC; Bevers MW; Levenback CF; Wolf JK; Bast RC; Freedman RS; Ippoliti C; Brewer M; Gajewski JL; Gershenson DM
    Bone Marrow Transplant; 2004 Jun; 33(12):1219-24. PubMed ID: 15122311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of autologous stem cell transplantation in the management of multiple myeloma.
    Fermand JP; Brechignac S
    Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.
    Morgan RJ; Doroshow JH; Leong L; Schriber J; Shibata S; Forman S; Hamasaki V; Margolin K; Somlo G; Alvarnas J; McNamara M; Longmate J; Raschko J; Chow W; Vasilev S; McGonigle K; Yen Y
    Bone Marrow Transplant; 2001 Nov; 28(9):859-63. PubMed ID: 11781646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tandem transplantation with peripheral autologous hematopoietic blood stem cells in treatment of oncologic and hematologic malignancies. Initial results of the Donauspital, Vienna].
    Ruckser R; Kier P; Sebesta C; Kittl E; Kurz M; Selleny S; Höniger S; Scherz M; Habertheuer KH; Zelenka P
    Wien Med Wochenschr; 1995; 145(2-3):41-4, 46-7. PubMed ID: 7762251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stem cell supported high dose chemotherapy (HDCT) in primary treatment of advanced ovarian carcinoma].
    Möbus V; von Schilling C; Kreienberg R; Wiesneth M; Bergmann L; Frickhofen N
    Praxis (Bern 1994); 1999 Mar; 88(12):507-12. PubMed ID: 10235025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.